{"content":"<li class=\"n-box-item date-title\" data-end=\"1496807999\" data-start=\"1496721600\" data-txt=\"Monday, December 23, 2019\">Tuesday, June  6, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3271990\" data-ts=\"1496792785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATH\" target=\"_blank\">ATH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271990-athene-holding-prices-secondary-offering-49-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athene Holding prices secondary offering at $49/share</a></h4><ul>   <li>Athene Holding (<a href=\"http://seekingalpha.com/symbol/ATH\" target=\"_blank\">ATH</a> <font color='green'>+1.6%</font>) has <a href=\"https://seekingalpha.com/pr/16854616-athene-holding-ltd-announces-pricing-secondary-offering-common-shares\" target=\"_blank\">priced a secondary offering</a> of 16.2M shares.</li>    <li>The Class A common shares will be sold to the public at $49/share; all are being sold by certain shareholders and the company won't receive any proceeds.</li>    <li>Shares closed today at $49.59; they're <font color='green'>up 0.2%</font> after hours.</li>    <li>Underwriters have a 30-day greenshoe option to buy up to $2.43M more common shares at that offering price.</li>    <li>The offering's expected to close next Monday. Goldman Sachs, Barclays, Citigroup and Wells Fargo are acting as joint book-runners.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271990\" data-linked=\"Athene Holding prices secondary offering at $49/share\" data-tweet=\"$ATH - Athene Holding prices secondary offering at $49/share https://seekingalpha.com/news/3271990-athene-holding-prices-secondary-offering-49-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3271990-athene-holding-prices-secondary-offering-49-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271986\" data-ts=\"1496789789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRWI\" target=\"_blank\">DRWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271986-dragonwave-jumps-50-on-smartsky-contract-win\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DragonWave jumps 50% on SmartSky contract win</a></h4><ul>   <li>Nanocap DragonWave (<a href=\"http://seekingalpha.com/symbol/DRWI\" target=\"_blank\">DRWI</a> <font color='red'>-3%</font>) -- making its biggest moves lately on news of one contract win or another -- is now <font color='green'>up 50.2%</font> after hours on heavy volume after word of <a href=\"https://seekingalpha.com/pr/16854552-dragonwave-awarded-product-services-contract-smartsky-networks\" target=\"_blank\">winning a product/services contract</a> from SmartSky Networks.</li>    <li>SmartSky, a 4G LTE in-flight service provider in North America, will use Harmony Enhanced and Harmony Enhanced MC products for high-capacity backhaul.</li>    <li>The high system gain of Harmony Enhanced MC makes it suited for SmartSky's long path lengths, DragonWave says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271986\" data-linked=\"DragonWave jumps 50% on SmartSky contract win\" data-tweet=\"$DRWI - DragonWave jumps 50% on SmartSky contract win https://seekingalpha.com/news/3271986-dragonwave-jumps-50-on-smartsky-contract-win?source=tweet\" data-url=\"https://seekingalpha.com/news/3271986-dragonwave-jumps-50-on-smartsky-contract-win\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271983\" data-ts=\"1496786238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVT\" target=\"_blank\">INVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271983-inventergy-delisted-from-nasdaq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inventergy delisted from Nasdaq</a></h4><ul><li>Inventergy (<a href='https://seekingalpha.com/symbol/INVT' title='Inventergy Global, Inc.'>OTC:INVT</a>) <font color='red'>-7.2%</font>&nbsp;AH after disclosing that Nasdaq will <a href=\"https://seekingalpha.com/filing/3584065\" target=\"_blank\">delist</a> the company&rsquo;s stock and  suspend trading, effective at the open tomorrow.</li><li>INVT says it has been in compliance with the minimum bid price requirement and  is eligible for an additional 180 calendar days to regain compliance, and asks Nasdaq to reconsider the delisting determination.</li><li>Otherwise, it expects to trade on the OTC Markets under its current ticker  symbol.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271983\" data-linked=\"Inventergy delisted from Nasdaq\" data-tweet=\"$INVT - Inventergy delisted from Nasdaq https://seekingalpha.com/news/3271983-inventergy-delisted-from-nasdaq?source=tweet\" data-url=\"https://seekingalpha.com/news/3271983-inventergy-delisted-from-nasdaq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271978\" data-ts=\"1496785103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271978-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/CVNA' title='Carvana Co.'>CVNA</a> <font color='green'>+9.9%</font>. <a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies Inc.'>KEYS</a> <font color='green'>+6.6%</font>. <a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a> <font color='green'>+3.4%</font>. <a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='green'>+3.4%</font>. <a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='green'>+3.1%.&nbsp;</font></li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/DLTH' title='Duluth Holdings'>DLTH</a> <font color='red'>-8.6%</font>. <a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a> <font color='red'>-6.6%</font>. <a href='https://seekingalpha.com/symbol/RPD' title='Rapid7'>RPD</a> <font color='red'>-5.4%</font>. <a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='red'>-4.6%</font>. <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-4.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271978\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$CVNA $KEYS $IPG - After Hours Gainers / Losers https://seekingalpha.com/news/3271978-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3271978-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271973\" data-ts=\"1496783241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDT\" target=\"_blank\">IDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271973-legal-costs-ding-q3-profits-idt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Legal costs ding Q3 profits at IDT</a></h4><ul>   <li>IDT (<a href=\"http://seekingalpha.com/symbol/IDT\" target=\"_blank\">IDT</a> <font color='green'>+1.9%</font>) saw revenues grow but swung to losses in its <a href=\"https://seekingalpha.com/news/3271961-idt-corporation-reports-q3-results\" target=\"_blank\">fiscal Q3 results</a> which were hit by a charge for a legal settlement.</li>    <li>The company posted a loss from operations of $6.5M vs. a year-ago gain of $5.7M, incorporating a $10.2M legal charge. EBITDA slipped to $9.1M from $10.3M.</li>    <li>Non-GAAP EPS fell to $0.28 from the prior year's $0.38.</li>    <li>In its major segment, Telecom Platform Services, minutes of use rose 3.1% to 6.98B. Retail Communications MOU fell 20.4%; Wholesale Carrier Services' MOU rose 12.8%.</li>    <li>Revenue by segment: TPS, $360.8M (up 4.8%); UCaaS, $7.4M (up 19.4%); CPS, $1.3M (down 23.5%); other, $0.6M (down 80.6%).</li>    <li><a href=\"http://www.idt.net/ir\" target=\"_blank\">Conference call</a> will feature outlook and will come at 5:30 p.m. ET.</li>    <li>Shares are flat in after-hours action.</li>    <li><a href=\"https://seekingalpha.com/pr/16854515-idt-corporation-reports-third-quarter-fiscal-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3271973\" data-linked=\"Legal costs ding Q3 profits at IDT\" data-tweet=\"$IDT - Legal costs ding Q3 profits at IDT https://seekingalpha.com/news/3271973-legal-costs-ding-q3-profits-idt?source=tweet\" data-url=\"https://seekingalpha.com/news/3271973-legal-costs-ding-q3-profits-idt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271968\" data-ts=\"1496781701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271968-api-crude-inventories-fall-4_6m-barrels\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">API: Crude inventories fall 4.6M barrels</a></h4><ul><li>In that sizable 4.6M barrel draw was a 1.56M barrel decline in Cushing inventories. Gasoline stocks rose 4.08M barrels, and distillates were higher by 1.75M barrels.</li><li>That Cushing draw would be the largest since October.</li><li>Oil is nevertheless slipping a bit in late trade, with <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a><font color='red'> -0.6%</font>&nbsp;after hours.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3271968\" data-linked=\"API: Crude inventories fall 4.6M barrels\" data-tweet=\"$USO $OIL $UCO - API: Crude inventories fall 4.6M barrels https://seekingalpha.com/news/3271968-api-crude-inventories-fall-4_6m-barrels?source=tweet\" data-url=\"https://seekingalpha.com/news/3271968-api-crude-inventories-fall-4_6m-barrels\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271958\" data-ts=\"1496780479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271958-ambarella-beats-q1-estimates-revenue-guidance-weak-shares-down-5_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella beats Q1 estimates, revenue guidance weak; shares down 5.8%</a></h4><ul><li>        Ambarella (NASDAQ:<a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a>) Q1 report beat EPS and revenue estimates. Other key metrics include 64.3% gross margin and $420.2M in cash and equivalents.&nbsp;</li><li>        Q2 guidance includes revenue of $69M-$72M, just under the $72.35M consensus. Gross margin is expected between 62.0% and 63.5% with operating expenses in the range of $26M to $27.5M.</li><li>               Ambarella shares are&nbsp;<font color='red'>down 5.79%</font>&nbsp;aftermarket.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16854451-ambarella-inc-announces-first-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">Press release</a>&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3271942-ambarella-beats-0_03-beats-revenue\" target=\"_blank\">Ambarella beats by $0.03, beats on revenue</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271958\" data-linked=\"Ambarella beats Q1 estimates, revenue guidance weak; shares down 5.8%\" data-tweet=\"$AMBA - Ambarella beats Q1 estimates, revenue guidance weak; shares down 5.8% https://seekingalpha.com/news/3271958-ambarella-beats-q1-estimates-revenue-guidance-weak-shares-down-5_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3271958-ambarella-beats-q1-estimates-revenue-guidance-weak-shares-down-5_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271957\" data-ts=\"1496780431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAY\" target=\"_blank\">PLAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271957-dave-busters-lower-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dave &amp; Buster&#39;s lower after earnings</a></h4><ul> <li>Dave &amp; Buster's Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a>) reports comparable sales increased 2.2% in <a href=\"https://seekingalpha.com/pr/16854454-dave-and-buster-s-achieves-record-first-quarter-net-income-42_8-million\" target=\"_blank\">Q1</a> vs. +2.7% consensus estimate.</li> <li>EBITDA rose 22.5% to $88.2M during the quarter to account for 29.0% of sales, up from 27.5% a year ago.</li> <li>\"Through today, we have opened seven stores and have an additional five stores under construction. We now expect to open twelve new stores this year, representing 13% unit growth, at the top end of our previous guidance of eleven to twelve new stores,\" notes CEO Steve King.</li> <li>D&amp;B bumps full-year guidance higher just a bit after factoring in the quarterly results. The company sees revenue of $1.160B to $1.170B vs. $1.155B to $1.170B prior and $1.17B consensus.</li> <li>PLAY <font color='red'>-3.52%</font> AH to $67.70.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271957\" data-linked=\"Dave &amp; Buster&#39;s lower after earnings\" data-tweet=\"$PLAY - Dave &amp; Buster&#39;s lower after earnings https://seekingalpha.com/news/3271957-dave-busters-lower-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3271957-dave-busters-lower-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271955\" data-ts=\"1496780319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBDC\" target=\"_blank\">GBDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271955-golub-capital-down-1_2-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Golub Capital down 1.2% on capital raise</a></h4><ul><li>The company<a href=\"https://seekingalpha.com/pr/16854458-golub-capital-bdc-inc-announces-public-offering\" target=\"_blank\"> is selling 1.75M shares </a>with underwriter greenshoe of 262.5K shares.</li><li>The deal should be getting done at well north of book value, with today's close of $19.69 vs. March 31 NAV per share of $15.88.</li><li><a href='https://seekingalpha.com/symbol/GBDC' title='Golub Capital BDC'>GBDC</a>&nbsp;<font color='red'>-1.2%</font>&nbsp;to $19.46.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271955\" data-linked=\"Golub Capital down 1.2% on capital raise\" data-tweet=\"$GBDC - Golub Capital down 1.2% on capital raise https://seekingalpha.com/news/3271955-golub-capital-down-1_2-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3271955-golub-capital-down-1_2-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271953\" data-ts=\"1496780282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXAS\" target=\"_blank\">EXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271953-exact-sciences-inks-deal-underwriters-to-sell-up-to-8_05m-common-shares-shares-slip-5-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exact Sciences inks deal with underwriters to sell up to 8.05M common shares; shares slip 5% after hours</a></h4><ul><li>Exact Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a>) is down<font color='red'> 5%</font>&nbsp;after hours on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16854429-exact-sciences-announces-agreement-sell-7000-000-common-shares\" target=\"_blank\">deal </a>to sell 7M shares of common stock to a group &nbsp;of underwriters. The over-allotment is an additional 1.05M shares. Price and terms have yet to be announced.</li><li><strong>Update</strong>: The deal priced at $35. Shares are down&nbsp;<font color='red'>5%</font>&nbsp;premarket on Wednesday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271953\" data-linked=\"Exact Sciences inks deal with underwriters to sell up to 8.05M common shares; shares slip 5% after hours\" data-tweet=\"$EXAS - Exact Sciences inks deal with underwriters to sell up to 8.05M common shares; shares slip 5% after hours https://seekingalpha.com/news/3271953-exact-sciences-inks-deal-underwriters-to-sell-up-to-8_05m-common-shares-shares-slip-5-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3271953-exact-sciences-inks-deal-underwriters-to-sell-up-to-8_05m-common-shares-shares-slip-5-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271947\" data-ts=\"1496779845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVNA\" target=\"_blank\">CVNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271947-carvana-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carvana beats by $0.01, beats on revenue</a></h4><ul><li>Carvana (NYSE:<a href='https://seekingalpha.com/symbol/CVNA' title='Carvana Co.'>CVNA</a>): Q1 EPS of -$0.28 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $159M (+118.0% Y/Y) <font color='green'>beats by $1.3M</font>.</li><li>Shares <font color='green'>+4%</font>.</li><li><a href='https://seekingalpha.com/pr/16854440-carvana-announces-first-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3271947\" data-linked=\"Carvana beats by $0.01, beats on revenue\" data-tweet=\"$CVNA - Carvana beats by $0.01, beats on revenue https://seekingalpha.com/news/3271947-carvana-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3271947-carvana-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271930\" data-ts=\"1496778536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COG\" target=\"_blank\">COG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271930-cabot-oilplus-2-cb-and-iminus-10-after-macquarie-analyst-actions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cabot Oil +2%, CB&amp;I -10% after Macquarie analyst actions</a></h4><ul>     <li>Cabot Oil &amp; Gas (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='green'>+2.4%</font>) maintains strong gains after Macquarie <a href=\"http://thefly.com/thestreet/realmoney/index.php/COGid2562459/COG-Cabot-Oil--Gas-upgraded-to-Outperform-from-Neutral-at-Macquarie\" target=\"_blank\">upgrades</a> shares to Outperform from Neutral, saying the stock's recent pullback is overdone and expecting improved natural gas prices into the fall and tighter Marcellus differentials.</li><li>The firm also is making its presence felt in Chicago Bridge &amp;&nbsp;Iron (<a href='https://seekingalpha.com/symbol/CBI' title='Chicago Bridge & Iron Company'>CBI</a> <font color='red'>-9.9%</font>), whose shares have sank to 52-week lows after Macquarie <a href=\"https://twitter.com/thenotablecalls/status/872083801261961216\" target=\"_blank\">slashed its stock price target</a> to $11.50 from $18, saying the company has \"hidden debt.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271930\" data-linked=\"Cabot Oil +2%, CB&amp;I -10% after Macquarie analyst actions\" data-tweet=\"$COG $COG $CBI - Cabot Oil +2%, CB&amp;I -10% after Macquarie analyst actions https://seekingalpha.com/news/3271930-cabot-oilplus-2-cb-and-iminus-10-after-macquarie-analyst-actions?source=tweet\" data-url=\"https://seekingalpha.com/news/3271930-cabot-oilplus-2-cb-and-iminus-10-after-macquarie-analyst-actions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271923\" data-ts=\"1496776661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDSO\" target=\"_blank\">MDSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271923-medidata-solutions-shares-up-7_6-following-bofaml-initiation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medidata Solutions shares up 7.6% following BofAML initiation</a></h4><ul><li>        Bank of America Merrill Lynch <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+BofAMerrill+Lynch+Starts+Medidata+Solutions+%28MDSO%29+at+Buy/12982702.html\" target=\"_blank\">starts</a> Medidata Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MDSO' title='Medidata Solutions, Inc.'>MDSO</a>) with a Buy rating.&nbsp;</li><li>        Analyst Steven Valiquette writes in favor of Medidata&rsquo;s software as a service platform for healthcare growth and notes the company could benefit from the recent spike in contract research organization mergers and acquisitions.</li><li>           EPS estimates: FY17: $1.27; FY18: $1.57; FY19: $1.91. </li><li>           Price target: $85. </li><li> Medidata Solutions shares are&nbsp;<font color='green'>up 7.59%</font>.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3271923\" data-linked=\"Medidata Solutions shares up 7.6% following BofAML initiation\" data-tweet=\"$MDSO - Medidata Solutions shares up 7.6% following BofAML initiation https://seekingalpha.com/news/3271923-medidata-solutions-shares-up-7_6-following-bofaml-initiation?source=tweet\" data-url=\"https://seekingalpha.com/news/3271923-medidata-solutions-shares-up-7_6-following-bofaml-initiation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271921\" data-ts=\"1496776116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRED\" target=\"_blank\">FRED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271921-freds-weak-q1-and-potential-entry-of-amazon-weighs-on-drug-distributors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fred&#39;s weak Q1 and potential entry of Amazon weighs on drug distributors</a></h4><ul><li>Drug wholesalers are under pressure after discount pharmacy chain Fred's (<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='red'>-9.9%</font>) posted tepid Q1 results, highlighted by a 3% drop in sales and a loss/share of ($0.98), and the rumored entry of 800-pound gorilla Amazon into the business.</li><li>(<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color='red'>-2.3%</font>)(<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health Inc.'>CAH</a> <font color='red'>-2.1%</font>)(<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a> <font color='red'>-1.8%</font>)(<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color='red'>-1.8%</font>)(<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a> <font color='red'>-1.3%</font>)(<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a> <font color='red'>-1.1%</font>)</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3271921\" data-linked=\"Fred&#39;s weak Q1 and potential entry of Amazon weighs on drug distributors\" data-tweet=\"$FRED $FRED $MCK - Fred&#39;s weak Q1 and potential entry of Amazon weighs on drug distributors https://seekingalpha.com/news/3271921-freds-weak-q1-and-potential-entry-of-amazon-weighs-on-drug-distributors?source=tweet\" data-url=\"https://seekingalpha.com/news/3271921-freds-weak-q1-and-potential-entry-of-amazon-weighs-on-drug-distributors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271918\" data-ts=\"1496775621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271918-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/COVS' title='Covisint Corporation'>COVS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/SCWX' title='SecureWorks Corp.'>SCWX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Inc'>COUP</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271918\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$OCLR $COVS $LITE - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3271918-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3271918-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271916\" data-ts=\"1496775117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SM\" target=\"_blank\">SM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271916-sm-energyplus-8-after-raising-production-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SM Energy +8% after raising production guidance</a></h4><ul>     <li>SM&nbsp;Energy (<a href='https://seekingalpha.com/symbol/SM' title='SM Energy Company'>SM</a> <font color='green'>+8.1%</font>) surges after <a href=\"https://seekingalpha.com/pr/16853265-sm-energy-announces-operations-update-increasing-production-guidance-positive-early-viper\" target=\"_blank\">raising its Q2 production guidance</a> by 400K boe, citing the acceleration of completion activity at its core Eagle Ford program.</li><li>SM hikes its Q2 production guidance o 10.7M-11.1M boe and 43.2M-46.2M boe for FY 2017, and says the results should boost cash flow and capital cost savings.</li><li>SM says it has completed 31 wells in the Eagle Ford program  YTD and plans to complete 39 wells for the full year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271916\" data-linked=\"SM Energy +8% after raising production guidance\" data-tweet=\"$SM - SM Energy +8% after raising production guidance https://seekingalpha.com/news/3271916-sm-energyplus-8-after-raising-production-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3271916-sm-energyplus-8-after-raising-production-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271915\" data-ts=\"1496775001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHA\" target=\"_blank\">CHA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271915-fiber-optics-stocks-popping-after-huawei-telecom-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fiber-optics stocks popping after Huawei telecom deal</a></h4><ul><li>Tech giant Huawei <a href=\"http://www.lightreading.com/optical/huawei-helps-china-telecom-build-the-first-intelligent-all-optical-backbone-transport-network-in-china-/d/d-id/733447\" target=\"_blank\">announced</a> yesterday that the company had won a bid to create a fiber-optic network for China Telecom (NYSE:<a href='https://seekingalpha.com/symbol/CHA' title='China Telecom Corporation Limited'>CHA</a>). The Reconfigurable Optical Add/Drop Multiplexer, or ROADM, Network Project will take place along the Yangtze River. The project is the first intelligent ROADM WDM backbone network built in the country.</li><li>News of the project continues to boost fiber-optic stocks. Oclaro (<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a> <font color='green'>+12.6%</font>) rose the highest due to a preexisting supply relationship with China Telecom and the fact that the company provides the ROADM tech that&rsquo;s in the title of the project.</li><li>Also up are Finisar (<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> <font color='green'>+7.9%</font>), which makes ROADM line cards, and Lumentum (<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='green'>+11%</font>), an optical communications company. These fiber-optic companies also have existing business relationships in China, providing parts to ZTE and Huawei.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271915\" data-linked=\"Fiber-optics stocks popping after Huawei telecom deal\" data-tweet=\"$CHA $CHA $OCLR - Fiber-optics stocks popping after Huawei telecom deal https://seekingalpha.com/news/3271915-fiber-optics-stocks-popping-after-huawei-telecom-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3271915-fiber-optics-stocks-popping-after-huawei-telecom-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271913\" data-ts=\"1496773509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRU\" target=\"_blank\">PRU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271913-prudential-financialminus-2_2-on-investor-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prudential Financial -2.2% on investor day</a></h4><ul><li>The life insurers are mostly in the red today <a href=\"https://seekingalpha.com/news/3271889-10-year-treasury-yield-carves-new-2017-low\" target=\"_blank\">as the yield curve flattens</a> to its lowest level since September. The largest declines are being seen in Prudential Financial (<a href='https://seekingalpha.com/symbol/PRU' title='Prudential Financial, Inc.'>PRU</a> <font color='red'>-2.2%</font>) as that company makes it case at its investor day.</li><li>Noted among headwinds to earnings: Low interest rates, fee pressures - thanks to the trend toward lower cost/passive strategies, runoff of existing blocks of business, and regulatory uncertainty - of particular note is a slowdown in sales thanks to the DOL's fiduciary rule.</li><li><a href=\"http://www.investor.prudential.com/phoenix.zhtml?c=129695&amp;p=irol-irhome\" target=\"_blank\">Webcast and presentation slides</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3271913\" data-linked=\"Prudential Financial -2.2% on investor day\" data-tweet=\"$PRU - Prudential Financial -2.2% on investor day https://seekingalpha.com/news/3271913-prudential-financialminus-2_2-on-investor-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3271913-prudential-financialminus-2_2-on-investor-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271908\" data-ts=\"1496772139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271908-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/UAN' title='CVR Partners, LP'>UAN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SEMG' title='SemGroup Corporation'>SEMG</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CCLP' title='CSI Compressco LP'>CCLP</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SVM' title='Silvercorp Metals Inc.'>SVM</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271908\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$ZN $UAN $TRCH - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3271908-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3271908-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271904\" data-ts=\"1496770738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPGP\" target=\"_blank\">IPGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271904-ipg-photonicsplus-2_7-longbow-boosts-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IPG Photonics +2.7% as Longbow boosts to Buy</a></h4><ul>   <li>IPG Photonics (NASDAQ:<a href='https://seekingalpha.com/symbol/IPGP' title='IPG Photonics Corporation'>IPGP</a>) is <font color='green'>up 2.7%</font> to all-time highs after an upgrade to Buy at Longbow.</li>    <li>The firm joins a half-dozen analyst firms this year who have reiterated Buy ratings on the company.</li>    <li>Longbow has a $175 price target, implying 21% upside from today's higher price.</li>    <li>In its run to the new peak, IPGP is <font color='green'>up 47%</font> YTD and <font color='green'>up 66%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271904\" data-linked=\"IPG Photonics +2.7% as Longbow boosts to Buy\" data-tweet=\"$IPGP - IPG Photonics +2.7% as Longbow boosts to Buy https://seekingalpha.com/news/3271904-ipg-photonicsplus-2_7-longbow-boosts-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3271904-ipg-photonicsplus-2_7-longbow-boosts-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271902\" data-ts=\"1496770289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMC\" target=\"_blank\">OMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271902-omnicomminus-1_6-interpublicminus-3_5-macquarie-cuts-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omnicom -1.6%, Interpublic -3.5% as Macquarie cuts both to Neutral</a></h4><ul>   <li>Omnicom (NYSE:<a href='https://seekingalpha.com/symbol/OMC' title='Omnicom Group Inc.'>OMC</a>) is <font color='red'>1.6% lower</font> and Interpublic Group (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>) is <font color='red'>off 3.5%</font> as Macquarie downgrades both ad giants to Neutral ahead of a cyclical slowdown.</li>    <li>Leading economic indicators have begun to turn lower in the U.S., which would cap performance of cyclical media stocks, analyst Tim Nollen and team say. They've cut their price target on Omnicom to $83 from $90 (vs. current $83.09 price), and cut IPG's target to $24 from $28 (current price: $24.19).</li>    <li>Margins are likely still improving, but even as marketing technology changes, uncertainty around those changes along with pricing pressure will restrain revenues, Macquarie says.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271902\" data-linked=\"Omnicom -1.6%, Interpublic -3.5% as Macquarie cuts both to Neutral\" data-tweet=\"$OMC $OMC $IPG - Omnicom -1.6%, Interpublic -3.5% as Macquarie cuts both to Neutral https://seekingalpha.com/news/3271902-omnicomminus-1_6-interpublicminus-3_5-macquarie-cuts-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3271902-omnicomminus-1_6-interpublicminus-3_5-macquarie-cuts-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271901\" data-ts=\"1496770274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271901-trovagene-perks-up-ahead-of-next-weeks-corporate-presentation-ceo-welch-shares-ahead-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trovagene perks up ahead of next week&#39;s corporate presentation by CEO Welch, shares ahead 22%</a></h4><ul><li>Thinly traded nano cap Trovagene (<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='green'>+21.6%</font>) shows some life on almost a 4x surge in volume. Shares are up almost 60% since Wednesday in an effort to break out of a long-term downtrend that began about 10 months ago.</li><li>CEO Bill Welch is set for a corporate <a href=\"https://seekingalpha.com/pr/16849325-trovagene-present-marcum-2017-microcap-conference-june-15-new-york-city\" target=\"_blank\">presentation </a>at the Marcum 2017 MicroCap Conference on June 15.</li><li>The company is developing its liquid biopsy technology for use in cancer, but the going has been slow. It recently licensed a blood cancer candidate from Italian outfit Nerviano Medical Sciences.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3269901-trovagene-ok-phase-1-safety-profile-blood-cancer-candidate-pcmminus-075-phase-1-2-study-aml\" target=\"_blank\">Trovagene OK with Phase 1 safety profile of blood cancer candidate PCM-075; Phase 1/2 study in AML next; shares ahead 5%</a> (May 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271901\" data-linked=\"Trovagene perks up ahead of next week&#39;s corporate presentation by CEO Welch, shares ahead 22%\" data-tweet=\"$TROV - Trovagene perks up ahead of next week&#39;s corporate presentation by CEO Welch, shares ahead 22% https://seekingalpha.com/news/3271901-trovagene-perks-up-ahead-of-next-weeks-corporate-presentation-ceo-welch-shares-ahead-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3271901-trovagene-perks-up-ahead-of-next-weeks-corporate-presentation-ceo-welch-shares-ahead-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271900\" data-ts=\"1496769915\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABCO\" target=\"_blank\">ABCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271900-sales-process-progresses-for-advisory-board-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sales process progresses for The Advisory Board Company</a></h4><ul> <li>Shares of The Advisory Board Company (<a href='https://seekingalpha.com/symbol/ABCO' title='The Advisory Board Company'>ABCO</a> <font color='red'>-1.1%</font>) trade with some volatility after <a href=\"https://www.dealreporter.com/info/\" target=\"_blank\">DealReporter</a> suggests that while the company isn't seeing interest for various parts of the business, a single buyer isn't stepping out..</li> <li>Final bids are expected to be received this month or by the end of July.</li> <li>ABCO is up 55.3% YTD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3271900\" data-linked=\"Sales process progresses for The Advisory Board Company\" data-tweet=\"$ABCO - Sales process progresses for The Advisory Board Company https://seekingalpha.com/news/3271900-sales-process-progresses-for-advisory-board-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3271900-sales-process-progresses-for-advisory-board-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271897\" data-ts=\"1496769122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRDS\" target=\"_blank\">CRDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271897-crossroads-systems-loses-patent-appeal-case-shares-down-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crossroads Systems loses patent appeal case; shares down 38%</a></h4><ul><li>        Crossroads Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a>), an intellectual property licensing company, <a href=\"https://www.sec.gov/Archives/edgar/data/1093207/000114420417031197/v468537_8k.htm\" target=\"_blank\">announces</a> in an 8-K that a federal appeals court upheld a prior ruling that all of the included Crossroads patents feature &ldquo;unpatentable&rdquo; technology.</li><li>               The company considers the technology related to the patents &ldquo;fundamental to secure and efficient access to network storage systems.&rdquo;&nbsp;</li><li>               Crossroads has previously filed patent infringement lawsuits against Cisco, NetApp, and Oracle.&nbsp;</li><li>               Crossroads shares are&nbsp;<font color='red'>down over 38%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3271897\" data-linked=\"Crossroads Systems loses patent appeal case; shares down 38%\" data-tweet=\"$CRDS - Crossroads Systems loses patent appeal case; shares down 38% https://seekingalpha.com/news/3271897-crossroads-systems-loses-patent-appeal-case-shares-down-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3271897-crossroads-systems-loses-patent-appeal-case-shares-down-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271896\" data-ts=\"1496768871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JACK\" target=\"_blank\">JACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271896-morgan-stanley-sees-gains-for-jack-in-box\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley sees more gains for Jack In the Box</a></h4><ul> <li>Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+Comments/Jack+in+the+Box+%28JACK%29%3A+Street+Is+Underestimating+Free+Cash+Flow+Potential+-+Morgan+Stanley/12983060.html\" target=\"_blank\">keeps</a> Jack In The Box (<a href='https://seekingalpha.com/symbol/JACK' title='Jack In The Box Inc.'>JACK</a> <font color='green'>+1.1%</font>) rated at Overweight as it applauds the company's decision to explore strategic options for the Qdoba business.</li><li>The investment firm thinks that investors are underestimating the potential for Jack to generate free cash flow of up to $7 per share by 2019. Further reductions in general and adminsitrative expenses and leveraging oppportunities are also seen.</li><li>Shares of Jack In The Box hit an all-time high of $7.20 in morning trading before falling back.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3271896\" data-linked=\"Morgan Stanley sees more gains for Jack In the Box\" data-tweet=\"$JACK - Morgan Stanley sees more gains for Jack In the Box https://seekingalpha.com/news/3271896-morgan-stanley-sees-gains-for-jack-in-box?source=tweet\" data-url=\"https://seekingalpha.com/news/3271896-morgan-stanley-sees-gains-for-jack-in-box\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271894\" data-ts=\"1496768520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGLB\" target=\"_blank\">SGLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271894-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='green'>+7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271894\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$SGLB - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3271894-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3271894-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271895\" data-ts=\"1496768337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRC\" target=\"_blank\">MRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271895-mrc-global-started-buy-rating-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MRC Global started with Buy rating at Stifel</a></h4><ul><li>MRC&nbsp;Global (<a href='https://seekingalpha.com/symbol/MRC' title='MRC Global'>MRC</a> <font color='green'>+1.5%</font>) moves higher after Stifel initiates coverage with a <a href=\"https://www.streetinsider.com/New+Coverage/Stifel+Starts+MRC+Global+%28MRC%29+at+Buy/12980758.html\" target=\"_blank\">Buy rating</a> and a $22 price target, seeing a near-term boost from the increasing U.S. rig count  and impending well completions, which are a more meaningful driver of  revenue for the company.</li><li>Stifel particularly likes MRC's Process Solutions Group, which  generates significant revenue per well completion and which the firm believes  is poised to gain market share in the recovery.</li><li>MRC's customers use PVF and oilfield supplies in mission critical process  applications that require a high degree of product  knowledge, technical expertise and comprehensive value-added services.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271895\" data-linked=\"MRC Global started with Buy rating at Stifel\" data-tweet=\"$MRC - MRC Global started with Buy rating at Stifel https://seekingalpha.com/news/3271895-mrc-global-started-buy-rating-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3271895-mrc-global-started-buy-rating-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271890\" data-ts=\"1496768160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPIX\" target=\"_blank\">EPIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271890-essa-pharma-continues-slide-shares-down-36\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ESSA Pharma continues slide; shares down 36%</a></h4><ul><li>Buyers are nowhere to be found for thinly traded nano cap ESSA Pharma (<a href='https://seekingalpha.com/symbol/EPIX' title='ESSA Pharma, Inc.'>EPIX</a> <font color='red'>-35.7%</font>). Shares have cratered over 60% in a week.</li><li>Yesterday, the company <a href=\"https://seekingalpha.com/pr/16852712-essa-pharma-presents-data-phase-1-trial-epiminus-506-2017-asco-annual-meeting\" target=\"_blank\">announced </a>early-stage data on EPI-506 in 21 treatment-resistant prostate cancer patients at ASCO. The participants received orally available EPI-506 for an average of 87 days (21 days - 427 days). 81% (n=17/21) discontinued treatment due to progressive disease. Three of the four remaining patients have undergone prolonged treatment. PSA (prostate-specific antigen)&nbsp;declines of 4 - 29% were observed in the four at higher doses. Development continues.</li><li>#ASCO17</li></ul><div class=\"tiny-share-widget\" data-id=\"3271890\" data-linked=\"ESSA Pharma continues slide; shares down 36%\" data-tweet=\"$EPIX - ESSA Pharma continues slide; shares down 36% https://seekingalpha.com/news/3271890-essa-pharma-continues-slide-shares-down-36?source=tweet\" data-url=\"https://seekingalpha.com/news/3271890-essa-pharma-continues-slide-shares-down-36\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271891\" data-ts=\"1496767826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271891-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/FENX' title='Fenix Parts'>OTC:FENX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/COVS' title='Covisint Corporation'>COVS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CRDS' title='Crossroads Systems, Inc.'>CRDS</a> <font color='red'>-26%</font>. <a href='https://seekingalpha.com/symbol/HDS' title='HD Supply'>HDS</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/GENE' title='GENETIC TECHNOLOGIES LTD'>GENE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CONN' title='Conn&#39;s, Inc.'>CONN</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271891\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ZCOR $GIII $FENX - Midday Gainers / Losers https://seekingalpha.com/news/3271891-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3271891-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271888\" data-ts=\"1496766958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IAG\" target=\"_blank\">IAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271888-gold-pushes-to-highest-finish-in-seven-months-on-safe-haven-trade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold pushes to highest finish in seven months on safe-haven trade</a></h4><ul>     <li>Gold prices <a href=\"http://www.marketwatch.com/story/gold-rises-looks-to-settle-at-7-week-high-2017-06-06\" target=\"_blank\">head for their highest finish since November</a>, with analysts attributing at least some of the gains on safe-haven demand sparked by tensions in the Middle East; August gold currently <font color='green'>+1%</font> at $1,295.80/oz.; silver <font color='green'>+0.7%</font> at $17.70/oz.</li>     <li>With traders already favoring safety plays ahead of Thursday's U.K. election, European Central Bank announcement and former FBI director James Comey&rsquo;s Senate testimony, &ldquo;the conflict between Saudi Arabia and Qatar has taken this trade to another level altogether,&rdquo; says ThinkMarkets chief analyst Naeem Aslam.</li>     <li>Citigroup analysts take it all in stride, reiterating its view that precious metals may see <a href=\"http://www.barrons.com/articles/gold-gold-miners-glitter-where-are-prices-heading-1496764368\" target=\"_blank\">prices peak in the current quarter</a> \"absent a tail-risk event such as a non-Conservative majority [in the U.K.] prompting a safe-haven bid.&rdquo;</li><li>Mining names populate the list of today's biggest gainers: <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='green'>+8.8%</font>,  <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='green'>+8.1%</font>,  <a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color='green'>+7.3%</font>,  <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='green'>+6.7%</font>,    <a href='https://seekingalpha.com/symbol/BTG' title='B2Gold Corp.'>BTG</a> <font color='green'>+6.2%</font>, <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='green'>+6.2%</font>, <a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc'>AGI</a> <font color='green'>+6%</font>, <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color='green'>+5.9%</font>, <a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc'>NGD</a> <font color='green'>+5.9%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='green'>+5.8%</font>.</li><li>Also: ABX <font color='green'>+3.6%</font>, <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='green'>+4.3%</font>, <a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a> <font color='green'>+2.3%</font>, <a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='green'>+2.2%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color='green'>+2.6%</font>, <a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a> <font color='green'>+2.8%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/SLV' title='iShares Silver Trust ETF'>SLV</a>, <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/AGQ' title='ProShares Ultra Silver ETF'>AGQ</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/PSLV' title='Sprott Physical Silver Trust'>PSLV</a>, <a href='https://seekingalpha.com/symbol/SIL' title='Global X Silver Miners ETF'>SIL</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/USLV' title='VelocityShares 3x Long Silver ETN'>USLV</a>, <a href='https://seekingalpha.com/symbol/SIVR' title='Aberd Std Silvr Shs'>SIVR</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='Aberdn Std Gold Shs'>SGOL</a>, <a href='https://seekingalpha.com/symbol/ZSL' title='ProShares UltraShort Silver ETF'>ZSL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/DSLV' title='VelocityShares 3x Inverse Silver ETN'>DSLV</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/SLVP' title='iShares MSCI Global Silver Miners ETF'>SLVP</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/DBS' title='Invesco DB Silver ETF'>DBS</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/PSAU' title='Invesco Global Gold and Precious Metals Portfolio ETF'>PSAU</a>, <a href='https://seekingalpha.com/symbol/TGLDX' title='Tocqueville Gold Fund No Load'>TGLDX</a>, <a href='https://seekingalpha.com/symbol/USV' title='UBS ETRACS CMCI Silver Total Return ETN'>USV</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Ultra Gold Miners ETF'>GDXX</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3271888\" data-linked=\"Gold pushes to highest finish in seven months on safe-haven trade\" data-tweet=\"$IAG $IAG $GSV - Gold pushes to highest finish in seven months on safe-haven trade https://seekingalpha.com/news/3271888-gold-pushes-to-highest-finish-in-seven-months-on-safe-haven-trade?source=tweet\" data-url=\"https://seekingalpha.com/news/3271888-gold-pushes-to-highest-finish-in-seven-months-on-safe-haven-trade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271887\" data-ts=\"1496766691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271887-nomura-broadcom-losing-interest-in-toshiba-memory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura: Broadcom losing interest in Toshiba Memory</a></h4><ul>   <li>Is Broadcom (<a href=\"http://seekingalpha.com/symbol/AVGO\" target=\"_blank\">AVGO</a> <font color='green'>+0.8%</font>) in or out of the driver's seat in the talks to acquire Toshiba Memory (<a href=\"http://seekingalpha.com/symbol/TOSYY\" target=\"_blank\">TOSYY</a> <font color='green'>+3.1%</font>)? The company no longer appears interested in buying Toshiba's NAND unit, Nomura's Romit Shah writes after an earlier meeting with CEO Hock Tan.</li>    <li>That follows reports that Toshiba was considering <a href=\"https://seekingalpha.com/news/3271727-broadcom-chosen-toshiba-chip-buyer\" target=\"_blank\">giving Broadcom exclusive talks</a> to acquire the business (from Asahi), and that Western Digital (<a href=\"http://seekingalpha.com/symbol/WDC\" target=\"_blank\">WDC</a> <font color='green'>+0.2%</font>) is offering to compromise on the need for a majority stake to get involved (from Nikkei).</li>    <li>High capital intensity and an unappealing cyclical nature of the NAND business makes a Broadcom acquisition complicated, Shah writes, though saying the company isn't confirming or denying its lack of interest. Shah boosted Nomura's price target to $275 from $260, implying 8.2% upside, and reiterated a Buy rating. (h/t: Bloomberg)</li>    <li>Nikkei says Western Digital will scrap plans to take majority control and try to make the unit a subsidiary, with an agreement to limit its stake to 19.9%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271887\" data-linked=\"Nomura: Broadcom losing interest in Toshiba Memory\" data-tweet=\"$AVGO $AVGO $TOSYY - Nomura: Broadcom losing interest in Toshiba Memory https://seekingalpha.com/news/3271887-nomura-broadcom-losing-interest-in-toshiba-memory?source=tweet\" data-url=\"https://seekingalpha.com/news/3271887-nomura-broadcom-losing-interest-in-toshiba-memory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271881\" data-ts=\"1496764948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUE\" target=\"_blank\">BLUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271881-investors-giddy-over-bluebird-bio-shares-up-almost-40-since-last-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors giddy over bluebird bio, shares up almost 40% since last week</a></h4><ul><li>Normally, Phase 1 data won't move the needle much in a mid cap biotech, but bluebird bio (<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color='green'>+12.2%</font>) is an exception. Shares are up almost 40% in four trading days stoked by positive early-stage data on anti-BCMA CAR-T candidate bb2121. The company is developing the immunotherapy to treat multiple myeloma with partner Celgene.</li><li>In a little over a month, there will be an FDA Ad Com review of Novartis' CAR-T candidate CTL019. A positive vote should propel all CAR-T developers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3271654-celgene-bluebirds-anti-bcma-car-t-candidate-shows-significant-treatment-effect-early-stage\" target=\"_blank\">Celgene and bluebird's anti-BCMA CAR-T candidate shows significant treatment effect in early-stage multiple myeloma study; BLUE up 8%</a> (June 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271881\" data-linked=\"Investors giddy over bluebird bio, shares up almost 40% since last week\" data-tweet=\"$BLUE - Investors giddy over bluebird bio, shares up almost 40% since last week https://seekingalpha.com/news/3271881-investors-giddy-over-bluebird-bio-shares-up-almost-40-since-last-week?source=tweet\" data-url=\"https://seekingalpha.com/news/3271881-investors-giddy-over-bluebird-bio-shares-up-almost-40-since-last-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271883\" data-ts=\"1496764883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271883-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/FENX' title='Fenix Parts'>OTC:FENX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CVGW' title='Calavo Growers, Inc.'>CVGW</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LWAY' title='Lifeway Foods, Inc.'>LWAY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271883\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$GIII $FENX $THO - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3271883-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3271883-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271878\" data-ts=\"1496764045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271878-short-attack-launches-on-new-age-beverages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Short attack launches on New Age Beverages</a></h4><ul> <li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color='red'>dropped by about 4%</font> from its intra-day high after The Street Sweeper issued a <a href=\"http://www.thestreetsweeper.org/undersurveillance/New_Age_Beverages__NBEV___Investment_Junk_Food\" target=\"_blank\">short report</a> on the company.</li> <li>\"NBEV margins and cash flow to sales ratios are terrible,\" maintains the firm.</li> <li>\"We&rsquo;re not saying this is one of the worst companies we&rsquo;ve ever covered. The product category is appealing, though healthy drinks may be a fad and huge names are slurping up shelf space. But the market hasn&rsquo;t priced in the risk,\" reads the concluding shot from SS.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3271878\" data-linked=\"Short attack launches on New Age Beverages\" data-tweet=\"$NBEV - Short attack launches on New Age Beverages https://seekingalpha.com/news/3271878-short-attack-launches-on-new-age-beverages?source=tweet\" data-url=\"https://seekingalpha.com/news/3271878-short-attack-launches-on-new-age-beverages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271875\" data-ts=\"1496763414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271875-weak-day-for-retail-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak day for retail sector</a></h4><ul> <li>The SPDR S&amp;P Retail ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>) is <font color='red'>down 2.16%</font> as <a href=\"https://seekingalpha.com/news/3271865-department-store-stocks-rattled-macys-talks-shop\" target=\"_blank\">Macy's Analyst Day jitters</a> and a batch of weak earnings reports (G-III, Casey's, Michaels, Land's End) sway sentiment.</li> <li>Notable names in harm's way include Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='red'>-2%</font>), Wal-Mart (<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a> <font color='red'>-1.6%</font>), Barnes &amp; Noble (<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='red'>-1.5%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='red'>-2.2%</font>), Ascena Retail (<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='red'>-5.4%</font>), Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='red'>-4.7%</font>), L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-2.9%</font>) and Genesco (<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a> <font color='red'>-3.6%</font>).</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3271875\" data-linked=\"Weak day for retail sector\" data-tweet=\"$TGT $XRT $TGT - Weak day for retail sector https://seekingalpha.com/news/3271875-weak-day-for-retail-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3271875-weak-day-for-retail-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271871\" data-ts=\"1496762166\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPCI\" target=\"_blank\">IPCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271871-intellipharmaceutics-up-3-on-mallinckrodt-launch-of-generic-seroquel-xr-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intellipharmaceutics up 3% on Mallinckrodt launch of generic Seroquel XR in U.S.</a></h4><ul><li>Intellipharmaceutics International (<a href='https://seekingalpha.com/symbol/IPCI' title='IntelliPharmaCeutics International Inc'>IPCI</a> <font color='green'>+3.1%</font>) <a href=\"https://seekingalpha.com/pr/16853641-intellipharmaceutics-announces-launch-generic-seroquel-xr-mallinckrodt\" target=\"_blank\">announces </a>that distribution partner Mallinckrodt (<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt PLC'>MNK</a> <font color='red'>-1.4%</font>) has begun the U.S. commercial launch of its generic version of AstraZeneca's antidepressant <a href=\"https://www.seroquelxr.com/\" target=\"_blank\">Seroquel XR</a> (quetiapine fumarate extended-release tablets) for the treatment of schizophrenia and bipolar disorder.</li><li>According Symphony Health Solutions, the U.S. market is ~$842M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271871\" data-linked=\"Intellipharmaceutics up 3% on Mallinckrodt launch of generic Seroquel XR in U.S.\" data-tweet=\"$IPCI $IPCI $MNK - Intellipharmaceutics up 3% on Mallinckrodt launch of generic Seroquel XR in U.S. https://seekingalpha.com/news/3271871-intellipharmaceutics-up-3-on-mallinckrodt-launch-of-generic-seroquel-xr-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3271871-intellipharmaceutics-up-3-on-mallinckrodt-launch-of-generic-seroquel-xr-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271869\" data-ts=\"1496761749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271869-pandora-returning-gains-fueled-verizon-investment-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora returning gains fueled by Verizon investment chatter</a></h4><ul>   <li>Pandora Media (<a href=\"http://seekingalpha.com/symbol/P\" target=\"_blank\">P</a> <font color='red'>-6%</font>) is giving back gains fueled yesterday by the prospect of a $100M investment from Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>), as analysts weigh in on prospects.</li>    <li>The stock rose 1.9% yesterday on a report that the Verizon investment could come if Pandora didn't arrange its own outright sale to Sirius XM (<a href=\"http://seekingalpha.com/symbol/SIRI\" target=\"_blank\">SIRI</a> <font color='red'>-1.1%</font>).</li>    <li>Macquarie has reiterated its Hold rating and an $11 price target, implying 16% upside from yesterday's close.</li>    <li>Meanwhile, Wedbush's Michael Pachter is skeptical of a Verizon deal at all. \"I <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/06/9566095/michael-pachter-says-pandora-isnt-a-good-fit-for-verizon\" target=\"_blank\">don&rsquo;t think it&rsquo;s accurate</a>; think SIRI makes much more sense, don&rsquo;t see a fit with VZ at all,\" he told Benzinga.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271869\" data-linked=\"Pandora returning gains fueled by Verizon investment chatter\" data-tweet=\"$VZ $VZ $P - Pandora returning gains fueled by Verizon investment chatter https://seekingalpha.com/news/3271869-pandora-returning-gains-fueled-verizon-investment-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3271869-pandora-returning-gains-fueled-verizon-investment-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>62&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271866\" data-ts=\"1496761494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271866-fastenal-falls-on-may-sales-figures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal falls on May sales figures</a></h4><ul><li>Net sales up 14.9% to $383M; Daily sales growth of 9.7%. Total store count totaled 2,484 with nine stores opened YTD.</li><li>Macquarie analyst Hamzah Mazari <a href=\"http://www.marketwatch.com/story/fastenal-shares-slump-48-after-neutral-daily-may-sales-2017-06-06\" target=\"_blank\">said</a> he was expecting a growth rate of about 10%, but said it was net neutral for  Fastenal's (<a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a> <font color='red'>-4.8%</font>) stock with historical sequential trends slightly weaker.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271866\" data-linked=\"Fastenal falls on May sales figures\" data-tweet=\"$FAST - Fastenal falls on May sales figures https://seekingalpha.com/news/3271866-fastenal-falls-on-may-sales-figures?source=tweet\" data-url=\"https://seekingalpha.com/news/3271866-fastenal-falls-on-may-sales-figures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271865\" data-ts=\"1496761293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271865-department-store-stocks-rattled-macys-talks-shop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Department store stocks rattled as Macy&#39;s talks shop</a></h4><ul>     <li>There's some very anxious trading in the department store sector as Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='red'>-4.7%</font>) holds its analyst day event.</li>     <li>In early comments, Macy's execs issued a warning on margins, but also backed prior guidance. Seeking Alpha is monitoring the event and will post fresh updates here.</li>     <li><a href=\"http://investors.macysinc.com/phoenix.zhtml?p=irol-eventDetails&amp;c=84477&amp;eventID=5257618\" target=\"_blank\">Macy's Investor Meeting webcast</a></li>     <li>Movers: J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) <font color='red'>-3.5%</font>, Sears Holdings (SHLD) <font color='red'>-3.6%</font>, Kohl's (NYSE:<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a>) <font color='red'>-4.3%</font>, Bon-Ton Stores (<a href='https://seekingalpha.com/symbol/BONT' title='The Bon-Ton Stores, Inc.'>OTC:BONT</a>) <font color='red'>-5.9%</font>, Dillard's (NYSE:<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a>)&nbsp;<font color='red'>-3.4%</font>, Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>) <font color='red'>-1.5%</font>.</li> <li><strong>Update</strong>:&nbsp;Macy's CFO Karen Hoguet says Q2 gross margin rate is running a full percentage point below last year's level. The company is using cost-cutting measures, a merchandise re-alignment strategy and increased focus on the BackStage business in an effort to hold the bottom line.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271865\" data-linked=\"Department store stocks rattled as Macy&#39;s talks shop\" data-tweet=\"$M $M $JCP - Department store stocks rattled as Macy&#39;s talks shop https://seekingalpha.com/news/3271865-department-store-stocks-rattled-macys-talks-shop?source=tweet\" data-url=\"https://seekingalpha.com/news/3271865-department-store-stocks-rattled-macys-talks-shop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271838\" data-ts=\"1496761236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271838-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AMRI' title='Albany Molecular Research, Inc.'>AMRI</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AGLE' title='Aeglea BioTherapeutics'>AGLE</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271838\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$ZCOR $BLUE $KURA - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3271838-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3271838-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271860\" data-ts=\"1496760897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271860-amd-shares-up-6_6-on-cryptocurrency-demands-imac-inclusion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD shares up 6.6% on cryptocurrency demands, iMac inclusion</a></h4><ul><li>Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) is <a href=\"http://www.cnbc.com/2017/06/05/digital-currency-mining-is-boosting-demand-for-amds-graphics-cards.html\" target=\"_blank\">benefitting</a> from the continued popularity of cryptocurrency like Bitcoin because currency &ldquo;miners&rdquo; can use the company&rsquo;s powerful graphic cards as a way to &ldquo;mine&rdquo; for coins.</li><li>AMD graphics cards in the RX 500 series, which launched in April, are sold out at many online retailers due to the cryptocurrency demand. Bitcoin is up 160% this year.</li><li>AMD is also benefitting from Apple&rsquo;s announcement yesterday that the Vega graphics processors will appear in the new and revamped iMac line.</li><li>The inclusion of Vega is notable because Apple traditionally used integrated graphics and is now stepping towards dedicated graphics likely as a way to boost its virtual reality efforts.</li><li>AMD shares are&nbsp;<font color='green'>up 6.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271860\" data-linked=\"AMD shares up 6.6% on cryptocurrency demands, iMac inclusion\" data-tweet=\"$AMD - AMD shares up 6.6% on cryptocurrency demands, iMac inclusion https://seekingalpha.com/news/3271860-amd-shares-up-6_6-on-cryptocurrency-demands-imac-inclusion?source=tweet\" data-url=\"https://seekingalpha.com/news/3271860-amd-shares-up-6_6-on-cryptocurrency-demands-imac-inclusion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>73&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271859\" data-ts=\"1496760636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WGO\" target=\"_blank\">WGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271859-winnebago-and-thor-jump-rv-demand-picks-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Winnebago and Thor jump as RV demand picks up</a></h4><ul> <li>The latest issue of Black Book Market Insights contains an update on the recreational vehicles market.</li> <li>\"Summer has finally arrived, and retail sales remain strong. Towable sales at auction set yet another record last month, and although Motor Home values declined a bit, they are still up from two months ago if you eliminate the unexpected price spike which occurred last month. Auction volume (and conversion rates) continue to be high, increasing for the past several months, which indicates a strong demand for quality used units from RV dealers.\"</li> <li>Motor home stats: Average selling price up 2% Y/Y to $41,149. Auction volume +20% M/M.</li> <li>The read on demand bodes well for Winnebago (<a href='https://seekingalpha.com/symbol/WGO' title='Winnebago Industries, Inc.'>WGO</a> <font color='green'>+4.5%</font>) looking ahead. As for today, shares of WGO are following Thor Industries (<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='green'>+10.5%</font>) higher off that firm's <a href=\"https://seekingalpha.com/news/3271703-thor-industries-plus-11-percent-earnings-show-strong-rv-demand\" target=\"_blank\">strong earnings report</a>.</li> <li><a href=\"http://www.blackbook.com/wp-content/uploads/2017/06/MI_6_5_17.pdf\" target=\"_blank\">Full Black Book report</a> (.pdf)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3271859\" data-linked=\"Winnebago and Thor jump as RV demand picks up\" data-tweet=\"$WGO $WGO $THO - Winnebago and Thor jump as RV demand picks up https://seekingalpha.com/news/3271859-winnebago-and-thor-jump-rv-demand-picks-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3271859-winnebago-and-thor-jump-rv-demand-picks-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271854\" data-ts=\"1496759173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDS\" target=\"_blank\">HDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271854-hd-supplyminus-18-after-announcements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HD Supply -18% after announcements</a></h4><ul><li>Missing <a href=\"https://seekingalpha.com/news/3271735-hd-supply-misses-0_27-beats-revenue\" target=\"_blank\">earnings estimates</a>, future outlook, <a href=\"https://seekingalpha.com/news/3271754-hd-supply-sells-waterworks-2_5b\" target=\"_blank\">offloading Waterworks</a>, or a combination of factors?</li><li>HD Supply (NASDAQ:<a href='https://seekingalpha.com/symbol/HDS' title='HD Supply'>HDS</a>) is now <font color='red'>down 18%</font> in early trade after its premarket announcements.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271854\" data-linked=\"HD Supply -18% after announcements\" data-tweet=\"$HDS - HD Supply -18% after announcements https://seekingalpha.com/news/3271854-hd-supplyminus-18-after-announcements?source=tweet\" data-url=\"https://seekingalpha.com/news/3271854-hd-supplyminus-18-after-announcements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271853\" data-ts=\"1496758864\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KURA\" target=\"_blank\">KURA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271853-kura-oncology-on-volatility-halt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kura Oncology on volatility halt</a></h4><ul><li>Trading in micro cap Kura Oncology (<a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='green'>+6.5%</font>) has been suspended by Nasdaq due to volatility. Shares popped 13% in early trading.</li><li>CEO Troy Wilson, Ph.D., J.D. will deliver a corporate <a href=\"https://seekingalpha.com/pr/16846064-kura-oncology-participate-two-upcoming-investor-conferences\" target=\"_blank\">presentation </a>today at the Jefferies 2017 Global Healthcare Conference in New York.</li><li><strong>Update</strong>: Trading resumed at 10:19 ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271853\" data-linked=\"Kura Oncology on volatility halt\" data-tweet=\"$KURA - Kura Oncology on volatility halt https://seekingalpha.com/news/3271853-kura-oncology-on-volatility-halt?source=tweet\" data-url=\"https://seekingalpha.com/news/3271853-kura-oncology-on-volatility-halt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271852\" data-ts=\"1496758705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTDOY\" target=\"_blank\">NTDOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271852-jefferies-boosts-nintendo-target-on-switch-bullishness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies boosts Nintendo target on Switch bullishness</a></h4><ul>   <li>Nintendo's (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>) success with the new Switch console may <a href=\"http://www.cnbc.com/2017/06/06/nintendo-switch-console-may-earn-more-than-the-wii-jefferies-says.html\" target=\"_blank\">outdo earnings from its popular Wii</a>, Jefferies says in a note where it boosted its price target on the game maker.</li>    <li>Analyst Atul Goyal reiterated a Buy rating and raised Nintendo's target to &yen;57,500 from &yen;39,200, implying 66% upside from today's price (shares are <font color='green'>up 0.2%</font> in Tokyo).</li>    <li>Sharea are <font color='green'>up 1.6%</font> in early U.S. trading.</li>    <li>\"Switch has turned out to be a stealth hit and is positioned to drive Wii-type software sales and profits cycle,\" Goyal writes. \"Switch's appeal to core-gamers (vs. Wii to casual gamers) is likely to drive higher attach-rate and higher earnings than Wii-era.\"</li>    <li>The 12 months following the Wii's launch drove a 300% increase in Nintendo's Japanese shares, Goyal notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271852\" data-linked=\"Jefferies boosts Nintendo target on Switch bullishness\" data-tweet=\"$NTDOY - Jefferies boosts Nintendo target on Switch bullishness https://seekingalpha.com/news/3271852-jefferies-boosts-nintendo-target-on-switch-bullishness?source=tweet\" data-url=\"https://seekingalpha.com/news/3271852-jefferies-boosts-nintendo-target-on-switch-bullishness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271850\" data-ts=\"1496758311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZN\" target=\"_blank\">ZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271850-zion-oil-gasplus-14-israel-drilling-begins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zion Oil &amp; Gas +14% as Israel drilling begins</a></h4><ul><li>Zion Oil &amp;&nbsp;Gas (<a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+13.8%</font>) jumps on news that it had <a href=\"https://seekingalpha.com/pr/16851660-drilling-begins-zion-oil-and-gas-spuds-megiddo-jezreel-1-well\" target=\"_blank\">begun drilling</a> a deep well onshore Israel in the Jezreel Valley, with plans to drill multiple wells from the pad site depending on results.</li><li>ZN says it expects to drill through at least four different geological strata  with oil and gas potential.</li><li>Although ZN&rsquo;s 99K-acre license is onshore, the company notes it is entirely within the Levant Basin, which contains as much as 6.6M barrels of oil remaining to be found in the offshore portion.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271850\" data-linked=\"Zion Oil &amp; Gas +14% as Israel drilling begins\" data-tweet=\"$ZN - Zion Oil &amp; Gas +14% as Israel drilling begins https://seekingalpha.com/news/3271850-zion-oil-gasplus-14-israel-drilling-begins?source=tweet\" data-url=\"https://seekingalpha.com/news/3271850-zion-oil-gasplus-14-israel-drilling-begins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271839\" data-ts=\"1496757097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIGR\" target=\"_blank\">EIGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271839-eiger-completes-enrollment-in-mid-stage-study-of-exendin-9minus-39-in-post-bariatric\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eiger completes enrollment in mid-stage study of exendin 9-39 in post-bariatric hypoglycemia; shares up 2%</a></h4><ul><li>Thinly traded nano cap Eiger BioPharmaceuticals (<a href='https://seekingalpha.com/symbol/EIGR' title='Eiger BioPharmaceuticals, Inc.'>EIGR</a> <font color='green'>+2.2%</font>) heads north on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16853434-eiger-completes-enrollment-phase-2-multiple-ascending-dose-study-exendin-9minus-39-post\" target=\"_blank\">announcement </a>that enrollment has been completed in its <a href=\"https://clinicaltrials.gov/ct2/show/NCT02771574?term=exendin+9-39&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 multiple-ascending dose study</a> assessing subcutaneous exendin 9-39 for the treatment of post-bariatric surgery patients who are experiencing dangerously low postprandial blood glucose levels (post-bariatric hypoglycemia or PBH).</li><li>Results from 19 of 20 patients will be presented on June 11th at the American Diabetes Association meeting in San Diego.</li><li>About 200K Americans undergo bariatric surgery each year as a way to fight obesity. PBH occurs in 30K (~15%) cases.</li><li>Exendin 9-39 is a peptide the selectively targets and blocks GLP-1 receptors which normalizes insulin secretion by the pancreas and reduces PBH.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271839\" data-linked=\"Eiger completes enrollment in mid-stage study of exendin 9-39 in post-bariatric hypoglycemia; shares up 2%\" data-tweet=\"$EIGR - Eiger completes enrollment in mid-stage study of exendin 9-39 in post-bariatric hypoglycemia; shares up 2% https://seekingalpha.com/news/3271839-eiger-completes-enrollment-in-mid-stage-study-of-exendin-9minus-39-in-post-bariatric?source=tweet\" data-url=\"https://seekingalpha.com/news/3271839-eiger-completes-enrollment-in-mid-stage-study-of-exendin-9minus-39-in-post-bariatric\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271829\" data-ts=\"1496755757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271829-cti-bio-prices-preferred-stock-offering-2000-shares-ease-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CTI Bio prices preferred stock offering at $2,000; shares ease 3% premarket</a></h4><ul><li>CTI BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a>) is down&nbsp;<font color='red'>3%</font>&nbsp;premarket, albeit on only 57 shares, in response to the <a href=\"https://seekingalpha.com/pr/16853812-cti-biopharma-prices-underwritten-public-offering-45-million-convertible-preferred-stock\" target=\"_blank\">pricing </a>of its public offering of 22,500 shares of Series N-3 Preferred Stock at $2,000 per share.</li><li>Each Series N-3 share is convertible into 667 shares of common stock at $3.00. Closing date is June 9. Gross proceeds will be $45M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271829\" data-linked=\"CTI Bio prices preferred stock offering at $2,000; shares ease 3% premarket\" data-tweet=\"$CTIC - CTI Bio prices preferred stock offering at $2,000; shares ease 3% premarket https://seekingalpha.com/news/3271829-cti-bio-prices-preferred-stock-offering-2000-shares-ease-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3271829-cti-bio-prices-preferred-stock-offering-2000-shares-ease-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271828\" data-ts=\"1496755692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IAG\" target=\"_blank\">IAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271828-iamgoldplus-5-sumitomo-metal-to-buy-30-stake-in-cot-gold-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iamgold +5% as Sumitomo Metal to buy 30% stake in Ct gold project</a></h4><ul>     <li>Iamgold (NYSE:<a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a>) <font color='green'>+5.1%</font> premarket after Japan's Sumitomo Metal Mining Co. <a href=\"https://seekingalpha.com/pr/16853048-iamgold-announces-strategic-agreement-sumitomo-metal-mining-development-cote-gold\" target=\"_blank\">agrees to acquire</a> a 27.75% interest in the C&ocirc;t&eacute; gold mining project from the company for $195M.</li>     <li>IAG says the deal validates the intrinsic value of the C&ocirc;t&eacute; project and provides the financial capacity to move forward with development.</li>     <li>C&ocirc;t&eacute; has proven and probable reserves of 5.9M oz., a mine life of 17 years with mill throughput of 32K tons/day, and life of mine average annual production of 320K oz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271828\" data-linked=\"Iamgold +5% as Sumitomo Metal to buy 30% stake in Ct gold project\" data-tweet=\"$IAG - Iamgold +5% as Sumitomo Metal to buy 30% stake in Ct gold project https://seekingalpha.com/news/3271828-iamgoldplus-5-sumitomo-metal-to-buy-30-stake-in-cot-gold-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3271828-iamgoldplus-5-sumitomo-metal-to-buy-30-stake-in-cot-gold-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271827\" data-ts=\"1496755545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGLE\" target=\"_blank\">AGLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271827-aeglea-bio-prices-stock-offering-4_10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeglea Bio prices stock offering at $4.10</a></h4><ul><li>Aeglea BioTherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AGLE' title='Aeglea BioTherapeutics'>AGLE</a>) <a href=\"https://seekingalpha.com/pr/16853854-aeglea-biotherapeutics-prices-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 3M shares of common stock at $4.10 per share. Closing date is June 9.</li><li>Yesterday's close was $4.26.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271827\" data-linked=\"Aeglea Bio prices stock offering at $4.10\" data-tweet=\"$AGLE - Aeglea Bio prices stock offering at $4.10 https://seekingalpha.com/news/3271827-aeglea-bio-prices-stock-offering-4_10?source=tweet\" data-url=\"https://seekingalpha.com/news/3271827-aeglea-bio-prices-stock-offering-4_10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271826\" data-ts=\"1496755263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIHD\" target=\"_blank\">NIHD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271826-nii-holdingsplus-74-on-nextel-brazil-deal-ainmt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NII Holdings +74% on Nextel Brazil deal with AINMT</a></h4><ul>   <li>Wireless services firm NII Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a>) is <b><font color='green'>up 74%</font></b> premarket after word that AINMT will pay $50M for a <a href=\"https://seekingalpha.com/pr/16853173-nii-holdings-ainmt-announce-partnership-invest-nextel-brazils-growth-strategy\" target=\"_blank\">30% stake in Nextel Brazil</a>, along with an option for more.</li>    <li>The arrangement for the two to jointly own and operate the Nextel Holdings parent unit has an option for AINMT -- parent of Norway's Ice network -- to invest an extra $150M to end up with a 60% controlling stake. If it does, NII would contribute capital and retain a 40% stake.</li>    <li>AINMT will fund the initial $50M investment with a share issuance of $50M-$75M, fully underwritten at 110 Norwegian kroner/share.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271826\" data-linked=\"NII Holdings +74% on Nextel Brazil deal with AINMT\" data-tweet=\"$NIHD - NII Holdings +74% on Nextel Brazil deal with AINMT https://seekingalpha.com/news/3271826-nii-holdingsplus-74-on-nextel-brazil-deal-ainmt?source=tweet\" data-url=\"https://seekingalpha.com/news/3271826-nii-holdingsplus-74-on-nextel-brazil-deal-ainmt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271817\" data-ts=\"1496755108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271817-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='green'>+27%&nbsp;</font>on Q1 <a href=\"https://seekingalpha.com/news/3271745-g-iii-apparel-beats-0_22-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='green'>+20%</font>.</li>     <li>EBIO <font color='green'>+13%</font>&nbsp;on late-stage <a href=\"https://seekingalpha.com/news/3271003-eleven-bios-late-stage-study-vicinium-bladder-cancer-continue-planned-shares-10-percent\" target=\"_blank\">study</a> of Vicinium in bladder cancer to continue as planned.</li>     <li><a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='green'>+12%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3271673-thor-beats-0_23-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/AMRI' title='Albany Molecular Research, Inc.'>AMRI</a> <font color='green'>+9%</font>&nbsp;on Carlyle Group <a href=\"https://seekingalpha.com/news/3271804-carlyle-group-takes-albany-molecular-research-21_75-share-plus-9-percent-premarket\" target=\"_blank\">take over</a> Albany Molecular Research.</li>     <li><a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='green'>+9%</font>&nbsp;on positive <a href=\"https://seekingalpha.com/news/3271702-acorda-therapeutics-plus-8_5-percent-positive-results-parkinsons-disease-drug\" target=\"_blank\">results</a> in Parkinson's disease drug.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271817\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$GIII $ZCOR $SESN - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3271817-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3271817-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271820\" data-ts=\"1496754581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271820-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a>&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3271767-francescas-misses-0_02-misses-revenue\" target=\"_blank\">Q1 earnings</a> miss.</li><li><a href='https://seekingalpha.com/symbol/CONN' title='Conn&#39;s, Inc.'>CONN</a>&nbsp;<font color='red'>-9%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3271734-conns-beats-0_17-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/MIK' title='The Michaels Companies'>MIK</a>&nbsp;<font color='red'>-6%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3271748-michaels-companies-misses-0_03-misses-revenue\" target=\"_blank\">Q1 earnings</a> miss.</li><li><a href='https://seekingalpha.com/symbol/HDS' title='HD Supply'>HDS</a>&nbsp;<font color='red'>-5%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3271735-hd-supply-misses-0_27-beats-revenue\" target=\"_blank\">Q1 result</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3271820\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$FRAN $CONN $MIK - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3271820-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3271820-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271804\" data-ts=\"1496752533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRI\" target=\"_blank\">AMRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271804-carlyle-group-takes-out-albany-molecular-research-for-21_75-shareplus-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carlyle Group takes out Albany Molecular Research for $21.75/share; +9% premarket</a></h4><ul><li>Affiliates of The Carlyle Group and GTCR LLC have agreed to <a href=\"https://seekingalpha.com/pr/16853335-amri-signs-definitive-agreement-acquired-carlyle-group-gtcr-21_75-per-share-cash\" target=\"_blank\">acquire </a>Albany Molecular Research (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRI' title='Albany Molecular Research, Inc.'>AMRI</a>) for $21.75 per share. Albany's board has unanimously endorsed the deal.</li><li>The transaction will be financed with debt and equity.</li><li>Shares are up&nbsp;<font color='green'>9%</font>&nbsp;premarket on robust volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256178-albany-molecular-exploring-sale-shares-8-percent\" target=\"_blank\">Albany Molecular exploring sale; shares up 8%</a> (April 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271804\" data-linked=\"Carlyle Group takes out Albany Molecular Research for $21.75/share; +9% premarket\" data-tweet=\"$AMRI - Carlyle Group takes out Albany Molecular Research for $21.75/share; +9% premarket https://seekingalpha.com/news/3271804-carlyle-group-takes-out-albany-molecular-research-for-21_75-shareplus-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3271804-carlyle-group-takes-out-albany-molecular-research-for-21_75-shareplus-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271792\" data-ts=\"1496751344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBIO\" target=\"_blank\">CBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271792-ladenburg-likes-catalyst-bio-sees-163-upside-shares-ahead-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ladenburg likes Catalyst Bio, sees 163% upside; shares ahead 9% premarket</a></h4><ul><li>Nano cap Catalyst Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a>) perks up&nbsp;<font color='green'>9%</font>&nbsp;premarket on light volume on the heels of an <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Ladenburg+Thalmann+Starts+Catalyst+Biosciences+%28CBIO%29+at+Buy/12982560.html\" target=\"_blank\">upgrade </a>to Buy with an $11 (163% upside) price target by Ladenburg Thalmann.</li><li>Analyst Kevin DeGeeter bases his bullish view on prospects for the company's subcutaneous formulations of Factor VIIa and Factor IX for hemophilia A and hemophilia B patients who are not suitable for alternative prophylaxis approaches. He forecasts peak annual sales of $245M and $425M, respectively.</li><li>Key upcoming catalysts: presentation of interim Phase 1/2 data on Factor IX SQ in Q4 and the initiation of a Phase 2/3 trial of Factor VIIa SQ.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271792\" data-linked=\"Ladenburg likes Catalyst Bio, sees 163% upside; shares ahead 9% premarket\" data-tweet=\"$CBIO - Ladenburg likes Catalyst Bio, sees 163% upside; shares ahead 9% premarket https://seekingalpha.com/news/3271792-ladenburg-likes-catalyst-bio-sees-163-upside-shares-ahead-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3271792-ladenburg-likes-catalyst-bio-sees-163-upside-shares-ahead-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271788\" data-ts=\"1496751023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JASO\" target=\"_blank\">JASO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271788-ja-solar-gets-6_80-share-takeover-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JA Solar gets $6.80/share takeover bid</a></h4><ul><li>JA&nbsp;Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a>) <font color='green'>+4%</font> premarket after saying it received a non-binding <a href=\"https://seekingalpha.com/pr/16853366-ja-solar-announces-receipt-revised-non-binding-proposal-acquire-company\" target=\"_blank\">takeover offer</a> from CEO Baofang  Jin and a company directed by Baofang for $6.80/ADS, a 6.4% premium to yesterday's closing price.</li><li>JASO says a special board committee will review the offer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271788\" data-linked=\"JA Solar gets $6.80/share takeover bid\" data-tweet=\"$JASO - JA Solar gets $6.80/share takeover bid https://seekingalpha.com/news/3271788-ja-solar-gets-6_80-share-takeover-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3271788-ja-solar-gets-6_80-share-takeover-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271786\" data-ts=\"1496750688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRAN\" target=\"_blank\">FRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271786-francescas-lower-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Francesca&#39;s lower on earnings miss</a></h4><ul>     <li>Francesca's (NASDAQ:<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a>)&nbsp;reports comparable sales declined 5% in <a href=\"https://seekingalpha.com/pr/16853333-francesca-s-reports-first-quarter-fiscal-year-2017-financial-results\" target=\"_blank\">Q1</a>&nbsp;due to a decrease in boutique traffic and conversion rates.</li>     <li>Merchandise category sales:&nbsp;Apparel: $60.01M (+6%); Jewelry: $23.77M (-1%);&nbsp;Accessories: $13.98M (-4%);&nbsp;Gifts: $11.12M (-2%).</li>     <li>Gross margin rate down 110 bps to 45.2%.</li>     <li>SG&amp;A expense rate rose 280 bps to 38.3%.</li>     <li>Operating margin rate squeezed 390 bps to 6.9%.</li>     <li>Inventory -31.37% Y/Y to $31.37M.</li>     <li>Boutique count +42 Y/Y to 679.</li>     <li><b>Q2 Guidance</b>:&nbsp;Net sales: $120M to $124M; Comparable sales: -3% to +1%; EPS:&nbsp;$0.13 to $0.18.</li>     <li><b>FY2017 Guidance</b>: Net sales: $518M to $537M;&nbsp;Comparable-store sales: -2% to +2%;&nbsp;EPS: $1.07 to $1.17; Shares outstanding: 36.8M; Tax&nbsp;rate: 38%;&nbsp;Capital expenditure: $28M to $33M; New boutiques: ~60 to 65.</li>     <li>FRAN&nbsp;<font color='red'>-12.88%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271786\" data-linked=\"Francesca&#39;s lower on earnings miss\" data-tweet=\"$FRAN - Francesca&#39;s lower on earnings miss https://seekingalpha.com/news/3271786-francescas-lower-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3271786-francescas-lower-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271787\" data-ts=\"1496750658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASY\" target=\"_blank\">CASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271787-caseys-general-stores-falls-after-soft-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casey&#39;s General Stores falls after soft earnings</a></h4><ul> <li>Casey's General Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a>) trades lower after <a href=\"https://seekingalpha.com/pr/16852848-casey-s-reports-fiscal-2017-earnings-positioned-strong-future-growth\" target=\"_blank\">FQ4</a> results disappoint.</li> <li>Same-store grocery sales were down 0.5% during the quarter to miss the consensus estimate for a 1.4% gain. Grocey margin was 31.1%.</li> <li>Same-store gallons sold fell 0.5% vs. +1.4% expected. Fuel margin was 7.8%.</li> <li>Casey's sets FY18 Guidance for same-store fuel gallons sold growth of 1.0% to 2.0% with an average margin of $0.18 to $0.20. per gallon. The company also sees increasing same-store grocery and other merchandise sales at a 2.0% to 4.0% pave with average margin of 31.0% to 32.0%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3271669-caseys-general-stores-misses-0_09-misses-revenue\" target=\"_blank\">Caseys General Stores misses by $0.09, misses on revenue</a> (June 5)</li> <li>CASY <font color='red'>-5.58%</font> premarket to $110.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271787\" data-linked=\"Casey&#39;s General Stores falls after soft earnings\" data-tweet=\"$CASY - Casey&#39;s General Stores falls after soft earnings https://seekingalpha.com/news/3271787-caseys-general-stores-falls-after-soft-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3271787-caseys-general-stores-falls-after-soft-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271782\" data-ts=\"1496750584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVM\" target=\"_blank\">CVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271782-cel-sci-submits-fda-response-for-phase-3-head-and-neck-cancer-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CEL-SCI submits FDA response for its Phase 3 head and neck cancer trial</a></h4><ul> <li>CEL-SCI Corporation (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a>) <a href=\"https://seekingalpha.com/pr/16851944-cel-sci-submits-fda-response-phase-3-head-neck-cancer-trial\" target=\"_blank\">announces</a> that it has       responded to the FDA's most recent       communication about the clinical hold imposed on the       Company&rsquo;s <a href=\"http://www.cel-sci.com/cancer_multikine.html\" target=\"_blank\">Phase 3 head and neck cancer study</a> with <a href=\"http://www.cel-sci.com/what_is_multikine.html\" target=\"_blank\">Multikine</a> (Leukocyte       Interleukin).</li>          <li>The hold issues addressed in the FDA communication were that the study&rsquo;s       Investigator Brochure &#40;IB&#41; and the &ldquo;Dear Investigator&rdquo; letter need to be       revised. CEL-SCI has revised the documents as directed by the agency and expects the hold to be lifted.</li>     <li>928 patients have been enrolled, treated, and are now being followed for study&rsquo;s primary endpoint.</li>     <li>The study endpoint is a 10% increase in overall survival of patients       between the two main groups receiving       the Multikine treatment regimen.</li><li>Shares are up&nbsp;<font color='green'>6%</font>&nbsp;premarket on light volume.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3271782\" data-linked=\"CEL-SCI submits FDA response for its Phase 3 head and neck cancer trial\" data-tweet=\"$CVM - CEL-SCI submits FDA response for its Phase 3 head and neck cancer trial https://seekingalpha.com/news/3271782-cel-sci-submits-fda-response-for-phase-3-head-and-neck-cancer-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/3271782-cel-sci-submits-fda-response-for-phase-3-head-and-neck-cancer-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271783\" data-ts=\"1496750321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VKTX\" target=\"_blank\">VKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271783-vikings-vk2809-shows-treatment-effect-in-nash-in-preclinical-testing-shares-ahead-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viking&#39;s VK2809 shows treatment effect in NASH in preclinical testing; shares ahead 13% premarket</a></h4><ul><li>Thinly traded nano cap Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a>) is up&nbsp;<font color='green'>13%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16853311-viking-therapeutics-announces-promising-top-line-results-vivo-study-vk2809-non-alcoholic\" target=\"_blank\">announcement </a>of encouraging preclinical results for NASH candidate VK2809.</li><li>In a mouse model of diet-induced NASH, treatment with orally available VK2809 for eight weeks resulted in statistically significant improvements in non-alcoholic fatty liver disease activity score &#40;NAS&#41;, liver collagen content and liver fibrosis compared to controls. The company says this is the first evidence of a thyromimetic agent demonstrating histologic benefits in a NASH model. It plans to continue development.</li><li>Specific treatment effects included a 70% reduction in liver triglyceride, a 65% reduction in liver cholesterol and a 50% drop in fibrosis, versus active control.</li><li><a href=\"http://www.vikingtherapeutics.com/pipeline/vk0214/\" target=\"_blank\">VK2809&nbsp;</a>is an orally available, tissue and receptor-subtype selective agonist of the thyroid beta receptor. It belongs to a family of novel prodrugs which are cleaved&nbsp;in vivo&nbsp;to release potent thyromimetics (producing effects similar to thyroid hormones).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3242037-vikings-vk2809-shows-positive-effect-poc-study-glycogen-storage-disease-shares-ahead-10\" target=\"_blank\">Viking's VK2809 shows positive effect in POC study in glycogen storage disease; shares ahead 10% premarket</a> (Feb. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271783\" data-linked=\"Viking&#39;s VK2809 shows treatment effect in NASH in preclinical testing; shares ahead 13% premarket\" data-tweet=\"$VKTX - Viking&#39;s VK2809 shows treatment effect in NASH in preclinical testing; shares ahead 13% premarket https://seekingalpha.com/news/3271783-vikings-vk2809-shows-treatment-effect-in-nash-in-preclinical-testing-shares-ahead-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3271783-vikings-vk2809-shows-treatment-effect-in-nash-in-preclinical-testing-shares-ahead-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271777\" data-ts=\"1496749731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271777-canadian-solarplus-1_6-after-q1-beat-solar-shipments-exceed-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Solar +1.6% after Q1 beat; solar shipments exceed guidance</a></h4><ul><li>Canadian Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a>) <font color='green'>+1.6%</font> premarket after beating estimates on <a href=\"https://seekingalpha.com/news/3271742-canadian-solar-beats-0_04-beats-revenue\" target=\"_blank\">Q1 earnings</a> and revenues, and exceeding guidance on solar shipments.</li><li>CSIQ reports Q1 solar module shipments were 1,480 MW, far better than company guidance of 1,150-1,200 MW but below 1,612 MW  in Q4 2016.</li><li>Q1 gross margin was 13.5%, compared to 13.9% (excluding the AD/CVD true-up  provision of $44.1M) or 7.3% (including the AD/CVD true-up  provision) in Q4; Q1 guidance was 13%-15%.</li><li>For Q2, CSIQ sees total solar  module shipments of 1,530-1,580  MW, and says it is enjoying \"overwhelming demand\" for its solar modules in China and \"healthy\" demand in the  U.S., Europe and Japan; Q2 gross margin is forecast at 13%-15%, with revenues of $615M-$635M.</li><li>CSIQ expects its total worldwide module manufacturing capacity will exceed 7.0 GW by year-end 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271777\" data-linked=\"Canadian Solar +1.6% after Q1 beat; solar shipments exceed guidance\" data-tweet=\"$CSIQ - Canadian Solar +1.6% after Q1 beat; solar shipments exceed guidance https://seekingalpha.com/news/3271777-canadian-solarplus-1_6-after-q1-beat-solar-shipments-exceed-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3271777-canadian-solarplus-1_6-after-q1-beat-solar-shipments-exceed-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271769\" data-ts=\"1496748943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLT\" target=\"_blank\">EGLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271769-egalets-arymo-er-covered-large-u-s-payer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Egalet&#39;s ARYMO ER covered by large U.S. payer</a></h4><ul><li>Egalet (<a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a>) <a href=\"https://seekingalpha.com/pr/16853190-egalet-announces-arymo-er-added-large-payer-formulary\" target=\"_blank\">announces</a> that a large unnamed U.S. payer with 24M members will now cover its ARYMO ER (morphine sulfate) extended-release tablets. The coverage, effective immediately, also includes SPRIX (ketorolac tromethamine) Nasal Spray and will be in effect through 2018.</li><li><strong>Update</strong>: Shares are up<font color='green'> 22%</font>&nbsp;premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271769\" data-linked=\"Egalet&#39;s ARYMO ER covered by large U.S. payer\" data-tweet=\"$EGLT $ZCOR - Egalet&#39;s ARYMO ER covered by large U.S. payer https://seekingalpha.com/news/3271769-egalets-arymo-er-covered-large-u-s-payer?source=tweet\" data-url=\"https://seekingalpha.com/news/3271769-egalets-arymo-er-covered-large-u-s-payer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271755\" data-ts=\"1496748084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIII\" target=\"_blank\">GIII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271755-g-iii-apparel-raises-fy2018-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">G-III Apparel raises FY2018 guidance</a></h4><ul><li>G-III Apparel (NASDAQ:<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a>) reports net sales rose 16% in <a href=\"https://seekingalpha.com/pr/16853239-g-iii-apparel-group-ltd-announces-first-quarter-fiscal-2018-results\" target=\"_blank\">Q1</a> as&nbsp;wholesale business continues its strong growth and demonstrates the power of brand portfolio.</li><li>Gross margin rate improved 200 bps to 38.2%.</li><li>SG&amp;A expense rate grew 380 bps to 37.3%.</li><li>Inventory +9.7% to $445.97M.</li><li><b>Q2 Guidance</b>: Net sales: ~$520M; Net loss: $15M to $20M; Diluted EPS: -$0.30 to -$0.40; Adjusted EPS: -$0.24 to -$0.34.</li><li><b>FY2018 Guidance</b>:&nbsp;Net sales: ~$2.76B; D&amp;A: $39M;&nbsp;Interest and financing charges, net: $51M; Income tax expense: $23M to $27M;&nbsp;Net income: $52M to $57M; Diluted EPS: $1.04 to $1.14; Adjusted net income: ~$60M to $65M; Adjusted EPS: $1.20 to $1.30; Adjusted EBITDA: $178M to $186M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271755\" data-linked=\"G-III Apparel raises FY2018 guidance\" data-tweet=\"$GIII - G-III Apparel raises FY2018 guidance https://seekingalpha.com/news/3271755-g-iii-apparel-raises-fy2018-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3271755-g-iii-apparel-raises-fy2018-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271749\" data-ts=\"1496747214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LE\" target=\"_blank\">LE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271749-results-lands-end-fall-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Results at Lands&#39; End fall short</a></h4><ul> <li>Lands' End (NASDAQ:<a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a>) reports direct segment net revenue fell 1.7% to $228.3M in FQ1, while retail segment revenue was down 2.8% to $40.0M.</li> <li>Same-store sales rose 2.1% during the quarter.</li> <li>Gross margin fell 170 bps to 45.7% of sales vs. $46.9% expected.</li> <li>Adjusted EBITDA improved 30 bps to 0.5% of sales.</li> <li>The company ended the quarer with an inventory position of $309.91M, flat from a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3271740-lands-end-misses-0_02-misses-revenue\" target=\"_blank\">Lands' End misses by $0.02, misses on revenue</a> (June 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271749\" data-linked=\"Results at Lands&#39; End fall short\" data-tweet=\"$LE - Results at Lands&#39; End fall short https://seekingalpha.com/news/3271749-results-lands-end-fall-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3271749-results-lands-end-fall-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271736\" data-ts=\"1496744688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CONN\" target=\"_blank\">CONN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271736-on-conns-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Conn&#39;s Q1</a></h4><ul>     <li>Conn's (NASDAQ:<a href='https://seekingalpha.com/symbol/CONN' title='Conn&#39;s, Inc.'>CONN</a>) reports same-store sales squeezed 15.2% in <a href=\"https://seekingalpha.com/pr/16853153-conns-inc-reports-first-quarter-fiscal-2018-financial-results\" target=\"_blank\">Q1</a>.</li>     <li>Net sales by category:&nbsp;Furniture and mattress: $94.44M (-10.3%);&nbsp;Home appliance: $80.12M (-8.9%);&nbsp;Consumer electronics: $55.75M (-15.4%); Home office: $16.79M (-25.3%); Other: $4.26M (-13.9%);&nbsp;Repair service agreement commissions: $24.7M (-12.4%);&nbsp;Service revenues: $3.23M (-16.6%).</li>     <li>Credit revenue up 9.1% to $76.5M.</li>     <li>Furniture unit volume declined 24.1% &amp; mattress unit volume curbed 21.6%.</li>     <li>Home appliance unit volume slipped 9.7%.</li>     <li>Consumer electronic&nbsp;unit volume down 16%.</li>     <li>Home office unit volume fell 28.7%.</li>     <li>Retail gross margin improved 260 bps to 38.4%.</li>     <li>Operating margin rose 240 bps to 5.7%.</li>     <li>Retail store count +7 Y/Y to 115.</li>     <li><b>Q2 Guidance</b>: Same-store sales:&nbsp;down 12 % to 15%;&nbsp;Retail gross margin rate: 37.75% to 38.25%; SG&amp;A expense rate: 30.5% to 32%;&nbsp;Provision for bad debts: $52M to $56M;&nbsp;Finance charges and other revenues: $78M to $82M;&nbsp;Interest expense: $20.5M to $22.5M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271736\" data-linked=\"More on Conn&#39;s Q1\" data-tweet=\"$CONN - More on Conn&#39;s Q1 https://seekingalpha.com/news/3271736-on-conns-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3271736-on-conns-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":65,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}